Ciglitazone | 1695

An antidiabetic drug. A thiazolidinedione (TDZ) type of antihyperglycemic agent. It displays antihyperglycemic activity in genetically obese C57 Bl/6 ob/ob mice and is a selective PPARɣ agonist (EC₅₀ = 3 µM).

Ciglitazone is an antidiabetic drug. A thiazolidinedione (TDZ) type of antihyperglycemic agent. It displays antihyperglycemic activity in genetically obese C57 Bl/6 ob/ob mice and is a selective PPARɣ agonist (EC₅₀ = 3 µM).

1695 | Ciglitazone DataSheet

Alternate Name/Synonyms: (±)-5-[4-(1-Methylcyclohexylmethoxy)benzyl]thiazolidine-2,4-dione

Appearance: Off-white solid

Formulation: N/A

CAS Number: 74772-77-3

Structure Available?: Yes

Peptide sequence: N/A

Salt Form: No

Molecular Formula: C₁₈H₂₃NO₃S

Molecular Weight: 333.45

Cell-Permeable?: Yes

Purity: ≥95% by HPLC

Solubilities: DMSO (25 mg/ml) or Ethanol (25 mg/ml)

Handling: Protect from air and light

Country of Origin: USA

Tag Line: A selective PPARɣ agonist

MDL Number: MFCD00865499

PubChem CID: 2750

SMILES: CC1(CCCCC1)COC2=CC=C(C=C2)CC3C(=O)NC(=O)S3

InChi: InChI=1S/C18H23NO3S/c1-18(9-3-2-4-10-18)12-22-14-7-5-13(6-8-14)11-15-16(20)19-17(21)23-15/h5-8,15H,2-4,9-12H2,1H3,(H,19,20,21)

InChi Key: YZFWTZACSRHJQD-UHFFFAOYSA-N